[Gastroenterology and hepatology in 2019].

This article aims to review the most important innovations and updates in gastroenterology and hepatology in 2019. The role of ursodesoxycholic acid is questioned in cholestasis during pregnancy. Aspirin appears to prevent fibrotic lesions in NALFD. Tenofovir remains the gold standard in the treatment (TT) of HBV during pregnancy. The role of carvedilol is confirmed in the TT of portal hypertension. The risk of degeneration of TIPMP lesions suggests increased surveillance. Colonoscopy should be systematic after an episode of acute diverticulitis. The surveillance of celiac disease is specified. Tofacitinib is an effective molecule in ulcerative colitis but precautions are needed. Budesonide tablet is validated for the TT of eosinophilic esophagitis.